• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA085901J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Death (1802)
Event Date 09/16/2020
Event Type  Death  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on (b)(6) 2020, the patient underwent endovascular procedure to treat chronic total occlusion (cto) of the left common iliac artery (cia) with kissing technique using two gore® viabahn® vbx balloon expandable endoprostheses.The procedure was successfully completed, and good blood flow was confirmed.The patient tolerated the procedure.On (b)(6) 2020, the patient presented with dull pain of abdominal area.Computed tomography (ct) suggested aneurysmal degeneration (mycotic aneurysm) around the endoprosthesis in the left cia (coded: aneurysm), and infection of the endoprosthesis was suspected.It was unknown which one of the two endoprostheses was involved in the suspected infection in the left cia.As it was considered the patient was high risk for surgery, the patient was being monitored in hospital with administration of antibiotics.On (b)(6) 2020, blood culture was positive.It was reported that causative agent was unknown.Also, the physician reportedly considered that there were some possible causes like intra-procedural manipulation or damage to the treatment area, and the cause or route of the infection was not able to be determined.On (b)(6) 2020, it was reported that the mycotic aneurysm ruptured.After ct confirmed the rupture with retroperitoneal bleeding, preparation of entering the operating room was being conducted, however, the patient expired.Reportedly, the cause of the death was bleeding due to the rupture of the mycotic aneurysm.It was also reported that the cause of the mycotic aneurysm was undeterminable.No autopsy was performed as the patient's family refused it.
 
Manufacturer Narrative
A review of the sterilization records for the device verified, that the lot met all pre-release specifications.
 
Manufacturer Narrative
H6 - added conclusion code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10804972
MDR Text Key215250481
Report Number2017233-2020-01424
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup,Followup
Report Date 05/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/12/2022
Device Catalogue NumberBXA085901J
Was Device Available for Evaluation? No
Date Manufacturer Received05/06/2021
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age70 YR
-
-